SLC6A19 Antibodies

Santa Cruz Biotechnology provides a broad selection of SLC6A19 monoclonal antibodies for research focused on understanding the function and regulation of SLC6A19. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SLC6A19 functions as a transporter protein responsible for neutral amino acid absorption in the intestine and kidney. Maintaining amino acid homeostasis depends on proper SLC6A19 function, and mutations in SLC6A19 genes can result in Hartnup disorder, characterized by amino acid malabsorption and related metabolic issues. Research into SLC6A19 continues to reveal its significance in cellular transport mechanisms and metabolic regulation. Understanding SLC6A19's role has become increasingly important for developing new therapeutic approaches. Investigating SLC6A19 expression patterns helps illuminate its involvement in various physiological processes. Current studies focus on how SLC6A19 dysfunction contributes to metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of amino acid transport systems and their impact on human health.